The order relates to an FTC demand in 2023 for business record from CVS in relation to a federal investigation into the alleged anticompetitive conduct of the company’s pharmacy-related operations.
"When we work together transparently, we not only solve immediate challenges but also unlock opportunities for industry-wide transformation.”
The order directs the Departments of the Treasury, Labor, and Health and Human Services to within 90 days come up with a framework to enforce Trump's 2019 executive order forcing health insurers and hospitals to disclose health care cost details.
An accompanying white paper was also released that provides detailed information on innovative programs from PCMA-member PBMs.
Customers can score free Kroger Hour Back Box filled with Our Brands breakfast essentials and more.
Among respondents who have used compounding pharmacies, over three-quarters (79%) report having a positive experience. However, only 42% of adults are familiar with pharmacy compounding.
"The Heritage Chocolate Society has paved the way for countless new ideas, exhibits and programming," says Kelly Lynch, Marketing Director, Mars Wrigley Premium Brands.
Inspired by a time-honored Sicilian tradition, Sanpellegrino CIAO! features a unique blend of real fruit juices and a pinch of Sicilian salt.
New 7.5 mg and 10 mg Zepbound single-dose vials now available for $499 per month via Zepbound Self Pay Journey Program.
The company estimates the first paper machine to be operational in the first part of 2028.
In an interview with David Pinto, McMillon discusses Walmart's past, present and future.
Future of Commerce 2030 event spotlights the power of partnerships and culture.
Is the CPG sector poised for long-term growth, or are brands adapting to an era of cautious consumer spending and inflation-driven price strategies?
Hy-Vee customers can round up during March to benefit food banks across the Midwest
Emory Healthcare Network is the first clinically integrated network in the country to include MinuteClinic as an in-network primary care provider.
SELARSDI is the second biosimilar to launch in the U.S. under the Teva and Alvotech strategic partnership, which includes nine products.
